Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03209713 · ClinicalTrials.gov registry record · NA

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

A NA study of Parents, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
672
Enrollment target
4
Study locations

NCT03209713: Active NA study of Parents, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03209713 is a NA study of Parents that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 672 participants, above the 250-participant average among 14 other Parents trials with a reported enrollment target (169% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03209713, a NA study of Parents, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
672 participants
Enrollment target
4
Study locations

Study Summary

This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.

Conditions Studied

Interventions

  • BEHAVIORAL HPV Vaccine Education
  • BEHAVIORAL Text Messaging Reminder

Study Locations (4)

Illinois

  • Alivio Medical Center - Chicago

Nevada

  • Research, Education and Access to Community Health (REACH) - Las Vegas

New York

  • Memorial Sloan Kettering Cancer Center - New York

Texas

  • The University of Texas at El Paso - El Paso

Trial Details

FieldValue
Enrollment Target 672 participants
Start Date 2017-06-28
Est. Completion 2026-06
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03209713

The ClinicalTrials.gov registry entry for NCT03209713 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 672 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 250-participant average among 14 other Parents trials with a reported enrollment target (169% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parents appearing as the primary indexed condition, and to 2 interventions - of which HPV Vaccine Education is the first listed.

NCT03209713 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Illinois, Nevada, New York.

Frequently Asked Questions

What is clinical trial NCT03209713 about?

NCT03209713 is a clinical study titled "Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination". This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have ...

What is the current status of trial NCT03209713?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 672 participants. The study started on 2017-06-28. Estimated completion is 2026-06.

What conditions does trial NCT03209713 study?

This clinical trial studies the following conditions: Parents.

What interventions are being tested in trial NCT03209713?

The interventions under investigation include: HPV Vaccine Education (BEHAVIORAL), Text Messaging Reminder (BEHAVIORAL).

Who is sponsoring clinical trial NCT03209713?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03209713 being conducted?

This trial has 4 study locations across Illinois, Nevada, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.